title: Inactivated vaccine against viral hemorrhagic septicemia (VHS) emulsified with squalene and aluminum hydroxide adjuvant provides long term protection in olive flounder (Paralichthys olivaceus).
abstract: Viral hemorrhagic septicemia (VHS) in olive flounder (Paralichthys olivaceus) remains an unsolved health problem in Korean aquaculture. Vaccination plays a significant role in modern aquaculture, and the duration of protection provided is of vital importance. Here, we have demonstrated the efficacy, duration of protection and safety of an inactivated vaccine emulsified with squalene (5%) and aluminum hydroxide (0.5%). The inactivated VHS vaccine provided a moderate protection of 37% and 47% relative percent survival (RPS) at 4 and 10 weeks post vaccination (wpv). Addition of squalene and aluminum hydroxide into inactivated VHS vaccine clearly enhanced the level of protection showing 58% and 83% RPS at 4 and 10 wpv, respectively, indicating the need for adjuvants to enhance the efficacy. The vaccinated fish showed significant protection at 3, 6, 12, 18, 24, and 40 wpv (except week 57) than non-vaccinated fish to an intraperitoneal challenge of 10(7.1)TCID₅₀/fish at 15 °C, with RPS of 60%, 64%, 71%, 55%, 52% and 50% (45% at 57 week), respectively, covering the duration of natural outbreak. Fish challenged at 18 wpv at 6 °C showed 56% RPS and protection at a low temperature. The antibody titer was high at 3 wpv with an OD of 1.08 ± 0.13, but decreased gradually and was undetectable by 24 wpv. The vaccine formulation was safe without injection site reactions, adhesions, or pigmentation observed at 6, 12, 18, or 24 wpv. Inflammatory reactions were observed in the spleen intestine at 6 and 12 wpv but were similar as control by 24 wpv. These results confirm that this vaccine is efficient and safe for olive flounder and could offer an appropriate strategy to prevent VHS without causing side effects.
authors.affiliation: Department of Aqualife Medicine, Chonnam National University, Republic of Korea.
authors.forename: Tharabenahalli-Nagaraju
authors.initials: TN
authors.lastname: Vinay
authors.forename: Ye-Ji
authors.initials: YJ
authors.lastname: Kim
authors.forename: Myung-Hwa
authors.initials: MH
authors.lastname: Jung
authors.forename: Wi-Sik
authors.initials: WS
authors.lastname: Kim
authors.forename: Do-Hyung
authors.initials: DH
authors.lastname: Kim
authors.forename: Sung-Ju
authors.initials: SJ
authors.lastname: Jung
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000536:Aluminum Hydroxide / Q000008:administration & dosage*; D000818:Animals; D000914:Antibodies, Viral / Q000097:blood; D017756:Aquaculture; D064420:Drug-Related Side Effects and Adverse Reactions / Q000453:epidemiology; D005393:Fish Diseases / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D005432:Flounder; D031941:Hemorrhagic Septicemia, Viral / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D007723:Korea; D013185:Squalene / Q000008:administration & dosage*; D016019:Survival Analysis; D016896:Treatment Outcome; D015164:Vaccines, Inactivated / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology; D014765:Viral Vaccines / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology*
chemical_list: D000276:Adjuvants, Immunologic; D000914:Antibodies, Viral; D015164:Vaccines, Inactivated; D014765:Viral Vaccines; D000536:Aluminum Hydroxide; D013185:Squalene
keywords: Adjuvant; Aluminum hydroxide; Olive flounder; Squalene emulsion; VHSV vaccine